Spinal Muscular Atrophy Treatment Market
1 Introduction to Research & Analysis Reports
1.1 Spinal Muscular Atrophy (SMA) Treatment Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Spinal Muscular Atrophy (SMA) Treatment Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Spinal Muscular Atrophy (SMA) Treatment Overall Market Size
2.1 Global Spinal Muscular Atrophy (SMA) Treatment Market Size: 2021 VS 2028
2.2 Global Spinal Muscular Atrophy (SMA) Treatment Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Spinal Muscular Atrophy (SMA) Treatment Players in Global Market
3.2 Top Global Spinal Muscular Atrophy (SMA) Treatment Companies Ranked by Revenue
3.3 Global Spinal Muscular Atrophy (SMA) Treatment Revenue by Companies
3.4 Top 3 and Top 5 Spinal Muscular Atrophy (SMA) Treatment Companies in Global Market, by Revenue in 2021
3.5 Global Companies Spinal Muscular Atrophy (SMA) Treatment Product Type
3.6 Tier 1, Tier 2 and Tier 3 Spinal Muscular Atrophy (SMA) Treatment Players in Global Market
3.6.1 List of Global Tier 1 Spinal Muscular Atrophy (SMA) Treatment Companies
3.6.2 List of Global Tier 2 and Tier 3 Spinal Muscular Atrophy (SMA) Treatment Companies
4 Market Sights by Product
4.1 Overview
4.1.1 by Type - Global Spinal Muscular Atrophy (SMA) Treatment Market Size Markets, 2021 & 2028
4.1.2 Type I Spinal Muscular Atrophy (SMA)
4.1.3 Type II Spinal Muscular Atrophy (SMA)
4.1.4 Type III Spinal Muscular Atrophy (SMA)
4.2 By Type - Global Spinal Muscular Atrophy (SMA) Treatment Revenue & Forecasts
4.2.1 By Type - Global Spinal Muscular Atrophy (SMA) Treatment Revenue, 2017-2022
4.2.2 By Type - Global Spinal Muscular Atrophy (SMA) Treatment Revenue, 2023-2028
4.2.3 By Type - Global Spinal Muscular Atrophy (SMA) Treatment Revenue Market Share, 2017-2028
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Spinal Muscular Atrophy (SMA) Treatment Market Size, 2021 & 2028
5.1.2 Hospitals
5.1.3 Ambulatory Surgical Centers
5.1.4 Diagnostic Centers
5.1.5 Others
5.2 By Application - Global Spinal Muscular Atrophy (SMA) Treatment Revenue & Forecasts
5.2.1 By Application - Global Spinal Muscular Atrophy (SMA) Treatment Revenue, 2017-2022
5.2.2 By Application - Global Spinal Muscular Atrophy (SMA) Treatment Revenue, 2023-2028
5.2.3 By Application - Global Spinal Muscular Atrophy (SMA) Treatment Revenue Market Share, 2017-2028
6 Sights by Region
6.1 By Region - Global Spinal Muscular Atrophy (SMA) Treatment Market Size, 2021 & 2028
6.2 By Region - Global Spinal Muscular Atrophy (SMA) Treatment Revenue & Forecasts
6.2.1 By Region - Global Spinal Muscular Atrophy (SMA) Treatment Revenue, 2017-2022
6.2.2 By Region - Global Spinal Muscular Atrophy (SMA) Treatment Revenue, 2023-2028
6.2.3 By Region - Global Spinal Muscular Atrophy (SMA) Treatment Revenue Market Share, 2017-2028
6.3 North America
6.3.1 By Country - North America Spinal Muscular Atrophy (SMA) Treatment Revenue, 2017-2028
6.3.2 US Spinal Muscular Atrophy (SMA) Treatment Market Size, 2017-2028
6.3.3 Canada Spinal Muscular Atrophy (SMA) Treatment Market Size, 2017-2028
6.3.4 Mexico Spinal Muscular Atrophy (SMA) Treatment Market Size, 2017-2028
6.4 Europe
6.4.1 By Country - Europe Spinal Muscular Atrophy (SMA) Treatment Revenue, 2017-2028
6.4.2 Germany Spinal Muscular Atrophy (SMA) Treatment Market Size, 2017-2028
6.4.3 France Spinal Muscular Atrophy (SMA) Treatment Market Size, 2017-2028
6.4.4 U.K. Spinal Muscular Atrophy (SMA) Treatment Market Size, 2017-2028
6.4.5 Italy Spinal Muscular Atrophy (SMA) Treatment Market Size, 2017-2028
6.4.6 Russia Spinal Muscular Atrophy (SMA) Treatment Market Size, 2017-2028
6.4.7 Nordic Countries Spinal Muscular Atrophy (SMA) Treatment Market Size, 2017-2028
6.4.8 Benelux Spinal Muscular Atrophy (SMA) Treatment Market Size, 2017-2028
6.5 Asia
6.5.1 By Region - Asia Spinal Muscular Atrophy (SMA) Treatment Revenue, 2017-2028
6.5.2 China Spinal Muscular Atrophy (SMA) Treatment Market Size, 2017-2028
6.5.3 Japan Spinal Muscular Atrophy (SMA) Treatment Market Size, 2017-2028
6.5.4 South Korea Spinal Muscular Atrophy (SMA) Treatment Market Size, 2017-2028
6.5.5 Southeast Asia Spinal Muscular Atrophy (SMA) Treatment Market Size, 2017-2028
6.5.6 India Spinal Muscular Atrophy (SMA) Treatment Market Size, 2017-2028
6.6 South America
6.6.1 By Country - South America Spinal Muscular Atrophy (SMA) Treatment Revenue, 2017-2028
6.6.2 Brazil Spinal Muscular Atrophy (SMA) Treatment Market Size, 2017-2028
6.6.3 Argentina Spinal Muscular Atrophy (SMA) Treatment Market Size, 2017-2028
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Spinal Muscular Atrophy (SMA) Treatment Revenue, 2017-2028
6.7.2 Turkey Spinal Muscular Atrophy (SMA) Treatment Market Size, 2017-2028
6.7.3 Israel Spinal Muscular Atrophy (SMA) Treatment Market Size, 2017-2028
6.7.4 Saudi Arabia Spinal Muscular Atrophy (SMA) Treatment Market Size, 2017-2028
6.7.5 UAE Spinal Muscular Atrophy (SMA) Treatment Market Size, 2017-2028
7 Players Profiles
7.1 Pfizer
7.1.1 Pfizer Corporate Summary
7.1.2 Pfizer Business Overview
7.1.3 Pfizer Spinal Muscular Atrophy (SMA) Treatment Major Product Offerings
7.1.4 Pfizer Spinal Muscular Atrophy (SMA) Treatment Revenue in Global Market (2017-2022)
7.1.5 Pfizer Key News
7.2 Isis Pharmaceuticals
7.2.1 Isis Pharmaceuticals Corporate Summary
7.2.2 Isis Pharmaceuticals Business Overview
7.2.3 Isis Pharmaceuticals Spinal Muscular Atrophy (SMA) Treatment Major Product Offerings
7.2.4 Isis Pharmaceuticals Spinal Muscular Atrophy (SMA) Treatment Revenue in Global Market (2017-2022)
7.2.5 Isis Pharmaceuticals Key News
7.3 Biogen Idec
7.3.1 Biogen Idec Corporate Summary
7.3.2 Biogen Idec Business Overview
7.3.3 Biogen Idec Spinal Muscular Atrophy (SMA) Treatment Major Product Offerings
7.3.4 Biogen Idec Spinal Muscular Atrophy (SMA) Treatment Revenue in Global Market (2017-2022)
7.3.5 Biogen Idec Key News
7.4 Boehringer Ingelheim
7.4.1 Boehringer Ingelheim Corporate Summary
7.4.2 Boehringer Ingelheim Business Overview
7.4.3 Boehringer Ingelheim Spinal Muscular Atrophy (SMA) Treatment Major Product Offerings
7.4.4 Boehringer Ingelheim Spinal Muscular Atrophy (SMA) Treatment Revenue in Global Market (2017-2022)
7.4.5 Boehringer Ingelheim Key News
7.5 F. Hoffmann-La Roche
7.5.1 F. Hoffmann-La Roche Corporate Summary
7.5.2 F. Hoffmann-La Roche Business Overview
7.5.3 F. Hoffmann-La Roche Spinal Muscular Atrophy (SMA) Treatment Major Product Offerings
7.5.4 F. Hoffmann-La Roche Spinal Muscular Atrophy (SMA) Treatment Revenue in Global Market (2017-2022)
7.5.5 F. Hoffmann-La Roche Key News
7.6 Regeneron Pharmaceuticals
7.6.1 Regeneron Pharmaceuticals Corporate Summary
7.6.2 Regeneron Pharmaceuticals Business Overview
7.6.3 Regeneron Pharmaceuticals Spinal Muscular Atrophy (SMA) Treatment Major Product Offerings
7.6.4 Regeneron Pharmaceuticals Spinal Muscular Atrophy (SMA) Treatment Revenue in Global Market (2017-2022)
7.6.5 Regeneron Pharmaceuticals Key News
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
List of Tables
Table 1. Spinal Muscular Atrophy (SMA) Treatment Market Opportunities & Trends in Global Market
Table 2. Spinal Muscular Atrophy (SMA) Treatment Market Drivers in Global Market
Table 3. Spinal Muscular Atrophy (SMA) Treatment Market Restraints in Global Market
Table 4. Key Players of Spinal Muscular Atrophy (SMA) Treatment in Global Market
Table 5. Top Spinal Muscular Atrophy (SMA) Treatment Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Spinal Muscular Atrophy (SMA) Treatment Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Spinal Muscular Atrophy (SMA) Treatment Revenue Share by Companies, 2017-2022
Table 8. Global Companies Spinal Muscular Atrophy (SMA) Treatment Product Type
Table 9. List of Global Tier 1 Spinal Muscular Atrophy (SMA) Treatment Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Spinal Muscular Atrophy (SMA) Treatment Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type ? Global Spinal Muscular Atrophy (SMA) Treatment Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Spinal Muscular Atrophy (SMA) Treatment Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Spinal Muscular Atrophy (SMA) Treatment Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application ? Global Spinal Muscular Atrophy (SMA) Treatment Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Spinal Muscular Atrophy (SMA) Treatment Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Spinal Muscular Atrophy (SMA) Treatment Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region ? Global Spinal Muscular Atrophy (SMA) Treatment Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Spinal Muscular Atrophy (SMA) Treatment Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Spinal Muscular Atrophy (SMA) Treatment Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Spinal Muscular Atrophy (SMA) Treatment Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Spinal Muscular Atrophy (SMA) Treatment Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Spinal Muscular Atrophy (SMA) Treatment Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Spinal Muscular Atrophy (SMA) Treatment Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Spinal Muscular Atrophy (SMA) Treatment Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Spinal Muscular Atrophy (SMA) Treatment Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Spinal Muscular Atrophy (SMA) Treatment Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Spinal Muscular Atrophy (SMA) Treatment Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Spinal Muscular Atrophy (SMA) Treatment Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Spinal Muscular Atrophy (SMA) Treatment Revenue, (US$, Mn), 2023-2028
Table 30. Pfizer Corporate Summary
Table 31. Pfizer Spinal Muscular Atrophy (SMA) Treatment Product Offerings
Table 32. Pfizer Spinal Muscular Atrophy (SMA) Treatment Revenue (US$, Mn), (2017-2022)
Table 33. Isis Pharmaceuticals Corporate Summary
Table 34. Isis Pharmaceuticals Spinal Muscular Atrophy (SMA) Treatment Product Offerings
Table 35. Isis Pharmaceuticals Spinal Muscular Atrophy (SMA) Treatment Revenue (US$, Mn), (2017-2022)
Table 36. Biogen Idec Corporate Summary
Table 37. Biogen Idec Spinal Muscular Atrophy (SMA) Treatment Product Offerings
Table 38. Biogen Idec Spinal Muscular Atrophy (SMA) Treatment Revenue (US$, Mn), (2017-2022)
Table 39. Boehringer Ingelheim Corporate Summary
Table 40. Boehringer Ingelheim Spinal Muscular Atrophy (SMA) Treatment Product Offerings
Table 41. Boehringer Ingelheim Spinal Muscular Atrophy (SMA) Treatment Revenue (US$, Mn), (2017-2022)
Table 42. F. Hoffmann-La Roche Corporate Summary
Table 43. F. Hoffmann-La Roche Spinal Muscular Atrophy (SMA) Treatment Product Offerings
Table 44. F. Hoffmann-La Roche Spinal Muscular Atrophy (SMA) Treatment Revenue (US$, Mn), (2017-2022)
Table 45. Regeneron Pharmaceuticals Corporate Summary
Table 46. Regeneron Pharmaceuticals Spinal Muscular Atrophy (SMA) Treatment Product Offerings
Table 47. Regeneron Pharmaceuticals Spinal Muscular Atrophy (SMA) Treatment Revenue (US$, Mn), (2017-2022)
List of Figures
Figure 1. Spinal Muscular Atrophy (SMA) Treatment Segment by Type in 2021
Figure 2. Spinal Muscular Atrophy (SMA) Treatment Segment by Application in 2021
Figure 3. Global Spinal Muscular Atrophy (SMA) Treatment Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Spinal Muscular Atrophy (SMA) Treatment Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Spinal Muscular Atrophy (SMA) Treatment Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Spinal Muscular Atrophy (SMA) Treatment Revenue in 2021
Figure 8. By Type - Global Spinal Muscular Atrophy (SMA) Treatment Revenue Market Share, 2017-2028
Figure 9. By Application - Global Spinal Muscular Atrophy (SMA) Treatment Revenue Market Share, 2017-2028
Figure 10. By Region - Global Spinal Muscular Atrophy (SMA) Treatment Revenue Market Share, 2017-2028
Figure 11. By Country - North America Spinal Muscular Atrophy (SMA) Treatment Revenue Market Share, 2017-2028
Figure 12. US Spinal Muscular Atrophy (SMA) Treatment Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Spinal Muscular Atrophy (SMA) Treatment Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Spinal Muscular Atrophy (SMA) Treatment Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Spinal Muscular Atrophy (SMA) Treatment Revenue Market Share, 2017-2028
Figure 16. Germany Spinal Muscular Atrophy (SMA) Treatment Revenue, (US$, Mn), 2017-2028
Figure 17. France Spinal Muscular Atrophy (SMA) Treatment Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Spinal Muscular Atrophy (SMA) Treatment Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Spinal Muscular Atrophy (SMA) Treatment Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Spinal Muscular Atrophy (SMA) Treatment Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Spinal Muscular Atrophy (SMA) Treatment Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Spinal Muscular Atrophy (SMA) Treatment Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Spinal Muscular Atrophy (SMA) Treatment Revenue Market Share, 2017-2028
Figure 24. China Spinal Muscular Atrophy (SMA) Treatment Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Spinal Muscular Atrophy (SMA) Treatment Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Spinal Muscular Atrophy (SMA) Treatment Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Spinal Muscular Atrophy (SMA) Treatment Revenue, (US$, Mn), 2017-2028
Figure 28. India Spinal Muscular Atrophy (SMA) Treatment Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Spinal Muscular Atrophy (SMA) Treatment Revenue Market Share, 2017-2028
Figure 30. Brazil Spinal Muscular Atrophy (SMA) Treatment Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Spinal Muscular Atrophy (SMA) Treatment Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Spinal Muscular Atrophy (SMA) Treatment Revenue Market Share, 2017-2028
Figure 33. Turkey Spinal Muscular Atrophy (SMA) Treatment Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Spinal Muscular Atrophy (SMA) Treatment Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Spinal Muscular Atrophy (SMA) Treatment Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Spinal Muscular Atrophy (SMA) Treatment Revenue, (US$, Mn), 2017-2028
Figure 37. Pfizer Spinal Muscular Atrophy (SMA) Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Isis Pharmaceuticals Spinal Muscular Atrophy (SMA) Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Biogen Idec Spinal Muscular Atrophy (SMA) Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Boehringer Ingelheim Spinal Muscular Atrophy (SMA) Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. F. Hoffmann-La Roche Spinal Muscular Atrophy (SMA) Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Regeneron Pharmaceuticals Spinal Muscular Atrophy (SMA) Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Industry Market Size
